AB0956 Leucine-rich alpha-2 glycoproteinis a predictable biomarker for therapeutic response and clinical relapse to biologics, but not to apremilast in patients with psoriasis
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.1660
Abstract: Background Leucine-rich alpha-2 glycoprotein (LRG) is a 50 kDa protein produced by hepatocytes, endothelial cells, neutrophils and macrophages, and it was identified as an inflammatory biomarker that correlates with the disease activity of autoimmune diseases such… read more here.
Keywords: biologics apremilast; leucine rich; serum lrg; biomarker ... See more keywords